Shweta A Raina1,2, Geoff G Z Zhang3, David E Alonzo3,4, Jianwei Wu3,5, Donghua Zhu3,6, Nathaniel D Catron3, Yi Gao7,8, Lynne S Taylor9. 1. Department of Industrial and Physical Pharmacy, College of Pharmacy, Purdue University, 575 Stadium Mall Drive, West Lafayette, Indiana, 47907, USA. 2. Manufacturing Science and Technology, Operations, AbbVie Inc., 1 North Waukegan Road, North Chicago, Illinois, 60064, USA. 3. Drug Product Development, Research and Development, AbbVie Inc., North Chicago, Illinois, USA. 4. Formulation & Process Development, Gilead Sciences Inc., Foster City, California, USA. 5. Center for Drug Evaluation and Research, FDA, Silver Spring, Maryland, USA. 6. Pharmaceutical Development Manufacturing & Science, Janssen R&D China, Johnson & Johnson, Shanghai, China. 7. Drug Product Development, Research and Development, AbbVie Inc., North Chicago, Illinois, USA. gao.yi@abbvie.com. 8. Manufacturing Science and Technology, Operations, AbbVie Inc., 1 North Waukegan Road, North Chicago, Illinois, 60064, USA. gao.yi@abbvie.com. 9. Department of Industrial and Physical Pharmacy, College of Pharmacy, Purdue University, 575 Stadium Mall Drive, West Lafayette, Indiana, 47907, USA. lstaylor@purdue.edu.
Abstract
PURPOSE: Many enabling formulations give rise to supersaturated solutions wherein the solute possesses higher thermodynamic activity gradients than the solute in a saturated solution. Since flux across a membrane is driven by solute activity rather than concentration, understanding how solute thermodynamic activity varies with solution composition, particularly in the presence of solubilizing additives, is important in the context of passive absorption. METHODS: In this study, a side-by-side diffusion cell was used to evaluate solute flux for solutions of nifedipine and felodipine in the absence and presence of different solubilizing additives at various solute concentrations. RESULTS: At a given solute concentration above the equilibrium solubility, it was observed that the solubilizing additives could reduce the membrane flux, indicating that the extent of supersaturation can be reduced. However, the flux could be increased back to the same maximum value (which was determined by the concentration where liquid-liquid phase separation (LLPS) occurred) by increasing the total solute concentration. Qualitatively, the shape of the curves of solute flux through membrane as a function of total solute concentration is the same in the absence and presence of solubilizing additives. Quantitatively, however, LLPS occurs at higher solute concentrations in the presence of solubilizing additives. Moreover, the ratios of the LLPS onset concentration and equilibrium solubility vary significantly in the absence and presence of additives. CONCLUSIONS: These findings clearly point out the flaws in using solute concentration in estimating solute activity or supersaturation, and reaffirm the use of flux measurements to understand supersaturated systems. Clear differentiation between solubilization and supersaturation, as well as thorough understanding of their respective impacts on membrane transport kinetics is important for the rational design of enabling formulations for poorly soluble compounds.
PURPOSE: Many enabling formulations give rise to supersaturated solutions wherein the solute possesses higher thermodynamic activity gradients than the solute in a saturated solution. Since flux across a membrane is driven by solute activity rather than concentration, understanding how solute thermodynamic activity varies with solution composition, particularly in the presence of solubilizing additives, is important in the context of passive absorption. METHODS: In this study, a side-by-side diffusion cell was used to evaluate solute flux for solutions of nifedipine and felodipine in the absence and presence of different solubilizing additives at various solute concentrations. RESULTS: At a given solute concentration above the equilibrium solubility, it was observed that the solubilizing additives could reduce the membrane flux, indicating that the extent of supersaturation can be reduced. However, the flux could be increased back to the same maximum value (which was determined by the concentration where liquid-liquid phase separation (LLPS) occurred) by increasing the total solute concentration. Qualitatively, the shape of the curves of solute flux through membrane as a function of total solute concentration is the same in the absence and presence of solubilizing additives. Quantitatively, however, LLPS occurs at higher solute concentrations in the presence of solubilizing additives. Moreover, the ratios of the LLPS onset concentration and equilibrium solubility vary significantly in the absence and presence of additives. CONCLUSIONS: These findings clearly point out the flaws in using solute concentration in estimating solute activity or supersaturation, and reaffirm the use of flux measurements to understand supersaturated systems. Clear differentiation between solubilization and supersaturation, as well as thorough understanding of their respective impacts on membrane transport kinetics is important for the rational design of enabling formulations for poorly soluble compounds.
Authors: Wenying Jian; Michelle V Romm; Richard W Edom; Vaughn P Miller; William A LaMarr; Naidong Weng Journal: Anal Chem Date: 2011-10-06 Impact factor: 6.986
Authors: Andy Z X Zhu; Ming-Chih David Ho; Christopher K Gemski; Bei-Ching Chuang; Mingxiang Liao; Cindy Q Xia Journal: AAPS J Date: 2016-09-06 Impact factor: 4.009
Authors: Anura S Indulkar; Huaping Mo; Yi Gao; Shweta A Raina; Geoff G Z Zhang; Lynne S Taylor Journal: Pharm Res Date: 2017-03-28 Impact factor: 4.200
Authors: Kaijie Qian; Lorenzo Stella; David S Jones; Gavin P Andrews; Huachuan Du; Yiwei Tian Journal: Pharmaceutics Date: 2021-06-15 Impact factor: 6.321